Evidence map›Paper›PMID 29335618›Full record

ArticleScientific reports2018

Long-Term Maintenance of Human Pluripotent Stem Cells on cRGDfK-Presenting Synthetic Surfaces.

Jack W Lambshead, Laurence Meagher, Jacob Goodwin, Tanya Labonne, Elizabeth Ng, Andrew Elefanty, Edouard Stanley, Carmel M O'Brien, Andrew L Laslett

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Synthetic alternatives to Matrigel.Nature reviews. Materials · 2020
    Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jack W LambsheadCSIRO Manufacturing, Clayton, Victoria, 3168, Australia.
Laurence MeagherMonash Institute of Medical Engineering, Monash University, Victoria, 3800, Australia.
Jacob GoodwinCSIRO Manufacturing, Clayton, Victoria, 3168, Australia.
Tanya LabonneMurdoch Children's Research Institute, The Royal Children's Hospital, Victoria, 3052, Australia.
Elizabeth NgMurdoch Children's Research Institute, The Royal Children's Hospital, Victoria, 3052, Australia.
Andrew ElefantyMurdoch Children's Research Institute, The Royal Children's Hospital, Victoria, 3052, Australia.
Edouard StanleyMurdoch Children's Research Institute, The Royal Children's Hospital, Victoria, 3052, Australia.
Carmel M O'BrienCSIRO Manufacturing, Clayton, Victoria, 3168, Australia.
Andrew L LaslettCSIRO Manufacturing, Clayton, Victoria, 3168, Australia. andrew.laslett@csiro.au.ORCID http://orcid.org/0000-0003-4729-8193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic human pluripotent stem cell (hPSC) culture surfaces with defined physical and chemical properties will facilitate improved research and therapeutic applications of hPSCs. In this study, synthetic surfaces for hPSC culture in E8 medium were produced for screening by modifying two polymer brush coatings [poly(acrylamide-co-acrylic acid) (PAAA) and poly(acrylamide-co-propargyl acrylamide) (PAPA)] to present single peptides. Adhesion of hPSC colonies was more consistently observed on surfaces modified with cRGDfK compared to surfaces modified with other peptide sequences tested. PAPA-coated polystyrene flasks with coupled cRGDfK (cRGDfK-PAPA) were then used for long-term studies of three hPSC lines (H9, hiPS-NHF1.3, Genea-02). Cell lines maintained for ten passages on cRGDfK-PAPA were assessed for colony morphology, proliferation rate, maintenance of OCT4 expression, cell viability at harvest, teratoma formation potential, and global gene expression as assessed by the PluriTest™ assay. cRGDfK-PAPA and control cultures maintained on Geltrex™ produced comparable results in most assays. No karyotypic abnormalities were detected in cultures maintained on cRGDfK-PAPA, while abnormalities were detected in cultures maintained on Geltrex™, StemAdhere™ or Synthemax™. This is the first report of long term maintenance of hPSC cultures on the scalable, stable, and cost-effective cRGDfK-PAPA coating.

Indexed as

Coated Materials, BiocompatiblePeptides, CyclicCell AdhesionCell Culture TechniquesCell ProliferationCell SurvivalCulture MediaGene Expression ProfilingHumansPluripotent Stem CellsSerial PassageCoated Materials, BiocompatibleCulture Mediacyclic (arginyl-glycyl-aspartyl-phenylalanyl-lysyl)Peptides, Cyclic

Identifiers

PMID29335618
PMCPMC5768753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.